Phase II study of neoadjuvant docetaxel, vinorelbine, and trastuzumab followed by surgery and adjuvant doxorubicin plus cyclophosphamide in women with human epidermal growth factor receptor 2-overexpressing locally advanced breast cancer (Q79766236)
Jump to navigation
Jump to search
scientific article published on 12 February 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase II study of neoadjuvant docetaxel, vinorelbine, and trastuzumab followed by surgery and adjuvant doxorubicin plus cyclophosphamide in women with human epidermal growth factor receptor 2-overexpressing locally advanced breast cancer |
scientific article published on 12 February 2007 |
Statements
Phase II study of neoadjuvant docetaxel, vinorelbine, and trastuzumab followed by surgery and adjuvant doxorubicin plus cyclophosphamide in women with human epidermal growth factor receptor 2-overexpressing locally advanced breast cancer (English)
Steven A Limentani
Adam M Brufsky
John K Erban
Mohammed Jahanzeb
12 February 2007